ATRenew (RERE) Cash & Equivalents (2019 - 2026)

ATRenew has reported Cash & Equivalents for 8 years, with the latest figure at $146.8 million in Q1 2026.

• Quarterly Cash & Equivalents fell 41.12% year-over-year to $146.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $146.8 million (down 41.12% YoY) and the FY2025 annual result came in at $219.9 million, down 18.55% from the prior year.
• Cash & Equivalents declined to $146.8 million in Q1 2026 per RERE's latest filing, from $216.8 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $274.8 million in Q4 2023 and troughed at $146.8 million in Q1 2026.
• A 5-year average of $213.0 million and a median of $216.8 million in 2025 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2022 and 2023: Cash & Equivalents tumbled 57.92% in 2022, then climbed 28.29% in 2023.
• Over 5 years, Cash & Equivalents stood at $239.5 million in 2022, then grew by 14.73% to $274.8 million in 2023, then fell by 0.19% to $274.3 million in 2024, then declined by 20.97% to $216.8 million in 2025, then sank by 32.28% to $146.8 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $146.8 million, $216.8 million, and $228.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.